/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development.
Independent Director nominee expected to be elected at Annual Shareholders Meeting in March 2024
CRANFORD, N.J., Jan. 23, 2024 /PRNewswire/ Citius Pharmaceuticals, Inc. , a late-stage.
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced the nomination of seasoned pharmaceutical.